Hypoxia-responsive nanoparticle based drug delivery systems in cancer therapy: An up-to-date review

Rashmi Kumari, Dhanya Sunil, Raghumani S. Ningthoujam

Research output: Contribution to journalReview article

Abstract

Hypoxia is a salient feature observed in most solid malignancies that holds a pivotal role in angiogenesis, metastasis and resistance to conventional cancer therapeutic approaches, and thus enables cancer progression. However, the typical characteristics of hypoxic cells such as low oxygen levels and highly bio-reductive environment can offer stimuli-responsive drug release to aid in tumor-specific chemo, radio, photodyanamic and sonodynamic therapies. This approach based on targeting the poorly oxygenated tumor habitats offers the prospective to overcome the difficulties that arises due to heterogenic nature of tumor and could be possibly used in the design of diagnostic as well as therapeutic nanocarriers for targeting various types of solid cancers. Consequently, hypoxia triggered nanoparticle based drug delivery systems is a rapidly progressing research area in developing effective strategies to combat drug-resistance in solid tumors. The present review presents the recent advances in the development of hypoxia-responsive nanovehicles for drug delivery to heterogeneous tumors. The initial sections of the article provides insights into the development of hypoxia in growing cancer and its role in disease progression. The current limitations and the future prospective of hypoxia-stimulated nanomachines for cancer treatment are also discussed.

Original languageEnglish
Pages (from-to)135-156
Number of pages22
JournalJournal of Controlled Release
Volume319
DOIs
Publication statusPublished - 10-03-2020

Fingerprint

Drug Delivery Systems
Nanoparticles
Neoplasms
Therapeutics
Hypoxia
Radio
Drug Resistance
Ecosystem
Disease Progression
Oxygen
Neoplasm Metastasis

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science

Cite this

@article{af33b8156d544bb998ccb28bd7f0f0d3,
title = "Hypoxia-responsive nanoparticle based drug delivery systems in cancer therapy: An up-to-date review",
abstract = "Hypoxia is a salient feature observed in most solid malignancies that holds a pivotal role in angiogenesis, metastasis and resistance to conventional cancer therapeutic approaches, and thus enables cancer progression. However, the typical characteristics of hypoxic cells such as low oxygen levels and highly bio-reductive environment can offer stimuli-responsive drug release to aid in tumor-specific chemo, radio, photodyanamic and sonodynamic therapies. This approach based on targeting the poorly oxygenated tumor habitats offers the prospective to overcome the difficulties that arises due to heterogenic nature of tumor and could be possibly used in the design of diagnostic as well as therapeutic nanocarriers for targeting various types of solid cancers. Consequently, hypoxia triggered nanoparticle based drug delivery systems is a rapidly progressing research area in developing effective strategies to combat drug-resistance in solid tumors. The present review presents the recent advances in the development of hypoxia-responsive nanovehicles for drug delivery to heterogeneous tumors. The initial sections of the article provides insights into the development of hypoxia in growing cancer and its role in disease progression. The current limitations and the future prospective of hypoxia-stimulated nanomachines for cancer treatment are also discussed.",
author = "Rashmi Kumari and Dhanya Sunil and Ningthoujam, {Raghumani S.}",
year = "2020",
month = "3",
day = "10",
doi = "10.1016/j.jconrel.2019.12.041",
language = "English",
volume = "319",
pages = "135--156",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",

}

Hypoxia-responsive nanoparticle based drug delivery systems in cancer therapy : An up-to-date review. / Kumari, Rashmi; Sunil, Dhanya; Ningthoujam, Raghumani S.

In: Journal of Controlled Release, Vol. 319, 10.03.2020, p. 135-156.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Hypoxia-responsive nanoparticle based drug delivery systems in cancer therapy

T2 - An up-to-date review

AU - Kumari, Rashmi

AU - Sunil, Dhanya

AU - Ningthoujam, Raghumani S.

PY - 2020/3/10

Y1 - 2020/3/10

N2 - Hypoxia is a salient feature observed in most solid malignancies that holds a pivotal role in angiogenesis, metastasis and resistance to conventional cancer therapeutic approaches, and thus enables cancer progression. However, the typical characteristics of hypoxic cells such as low oxygen levels and highly bio-reductive environment can offer stimuli-responsive drug release to aid in tumor-specific chemo, radio, photodyanamic and sonodynamic therapies. This approach based on targeting the poorly oxygenated tumor habitats offers the prospective to overcome the difficulties that arises due to heterogenic nature of tumor and could be possibly used in the design of diagnostic as well as therapeutic nanocarriers for targeting various types of solid cancers. Consequently, hypoxia triggered nanoparticle based drug delivery systems is a rapidly progressing research area in developing effective strategies to combat drug-resistance in solid tumors. The present review presents the recent advances in the development of hypoxia-responsive nanovehicles for drug delivery to heterogeneous tumors. The initial sections of the article provides insights into the development of hypoxia in growing cancer and its role in disease progression. The current limitations and the future prospective of hypoxia-stimulated nanomachines for cancer treatment are also discussed.

AB - Hypoxia is a salient feature observed in most solid malignancies that holds a pivotal role in angiogenesis, metastasis and resistance to conventional cancer therapeutic approaches, and thus enables cancer progression. However, the typical characteristics of hypoxic cells such as low oxygen levels and highly bio-reductive environment can offer stimuli-responsive drug release to aid in tumor-specific chemo, radio, photodyanamic and sonodynamic therapies. This approach based on targeting the poorly oxygenated tumor habitats offers the prospective to overcome the difficulties that arises due to heterogenic nature of tumor and could be possibly used in the design of diagnostic as well as therapeutic nanocarriers for targeting various types of solid cancers. Consequently, hypoxia triggered nanoparticle based drug delivery systems is a rapidly progressing research area in developing effective strategies to combat drug-resistance in solid tumors. The present review presents the recent advances in the development of hypoxia-responsive nanovehicles for drug delivery to heterogeneous tumors. The initial sections of the article provides insights into the development of hypoxia in growing cancer and its role in disease progression. The current limitations and the future prospective of hypoxia-stimulated nanomachines for cancer treatment are also discussed.

UR - http://www.scopus.com/inward/record.url?scp=85078734064&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85078734064&partnerID=8YFLogxK

U2 - 10.1016/j.jconrel.2019.12.041

DO - 10.1016/j.jconrel.2019.12.041

M3 - Review article

C2 - 31881315

AN - SCOPUS:85078734064

VL - 319

SP - 135

EP - 156

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

ER -